Clinical Trial Update: Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial update investigates pembrolizumab in combination with aflibercept in patients with advanced cancers, including melanoma, colorectal cancer, ovar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma
• Ovarian Cancer
• Renal Cell Carcinoma
• Sarcoma

Drugs mentioned

• Keytruda (Pembrolizumab) (pembrolizumab)
• Zaltrap (aflibercept) (aflibercept)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING